To amend title XI of the Social Security Act to require that direct-to-consumer advertisements for drugs and biologicals include an appropriate disclosure of pricing information.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, To amend title XI of the Social Security Act to require that direct-to-consumer advertisements for drugs and biologicals include an appropriate disclosure of pricing information., changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Government Operations, Foreign Policy.
Who Benefits and How
health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section H1A7E74CB1E424603940BA12B00C33F27: 1. Short title This Act may be cited as the Drug-price Transparency for Consumers Act of 2023 or the DTC Act of 2023.
- Section HD884842E4BEC4D14A495E54A460A5C7E: 2. Findings; sense of Congress Congress finds the following: Direct-to-consumer advertising of prescription pharmaceuticals is legally permitted in only 2...
- Section H7EAB7EB354054F4887A5F498F747B326: 3. Requirement that direct-to-consumer advertisements for drugs and biologicals include an appropriate disclosure of pricing information Part A of title XI of...
- Section H44B12EEF56FB46919EA13BA97BC0E82E: 1150D. Requirement that direct-to-consumer advertisements for drugs and biologicals include an appropriate disclosure of pricing information Subject to...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, To amend title XI of the Social Security Act to require that direct-to-consumer advertisements for drugs and biologicals include an appropriate disclosure of pricing information., changes federal law or congressional policy affecting health care providers and patients.
Key Policy Areas
Healthcare, Government Operations, Foreign Policy
Primary Purpose
This bill, To amend title XI of the Social Security Act to require that direct-to-consumer advertisements for drugs and biologicals include an appropriate disclosure of pricing information., changes federal law or congressional policy affecting health care providers and patients.
Policy Domains
Whole bill
Identified Gains
- health care providers and patients
Identified Costs
- federal implementing agencies
- health care providers and patients
Sponsors
Legislative Progress
In CommitteeReferred to the Committee on Energy and Commerce, and in …
Ms. Spanberger (for herself and Mr. Nunn of Iowa) introduced …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_administrator"
- → The Administrator identified in the operative section
- "secretary_of_health_and_human_services"
- → Secretary of Health and Human Services
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology